BRCA1 germline mutations confer susceptibility to familial breast and ovarian cancer. Mutational hot spots have never been detected in BRCA1 cDNA. Some mutations have been reported several times whereas some others appear to be population-related. In this study a group of 36 Italian families were analysed for BRCA1 germline mutations. All of them were screened by allele-specific oligonucleotide hybridization (ASO) for three recurrent mutations (185delAG, 5382insC, nt332-T>G). Twenty families, selected because of their high risk of carrying BRCA1 mutations, were subjected to analysis of the entire coding sequence of the gene. A total of eight mutations were found. ASO screening demonstrated only one known mutation in one patient, whereas cycle sequencing revealed five new mutations. Three of these new mutations were frameshifts: one occurred in exon 11 (1499insA), one in exon 16 (4873delCA) and one in the splice site of exon 3 (252delAAgt). Two were missense mutations (Cys64Arg; Asn158Tyr). The same frameshift mutation, 1499insA, was detected in three unrelated families. Haplotype analysis supported the hypothesis that two of these families may have had common ancestors, whereas in the third family the analysis was uninformative. BRCA1 germline mutations were found in one out of two families with ovarian cancer, in five out of eight families with breast-ovarian cancer, and in two out of 11 families with breast cancer. All three families with 1499insA mutations included at least one case of ovarian cancer. The majority of the ovarian cancers (4/5) associated with detectable BRCA1 germline mutations were of serous histotype.

BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations / M. A., Caligo; C., Ghimenti; G., Cipollini; S., Ricci; I., Brunetti; V., Marchetti; R., Olsen; S., Neuhausen; D., Shattuck Eidens; Conte, Pierfranco; M. H., Skolnick; G., Bevilacqua. - In: ONCOGENE. - ISSN 0950-9232. - STAMPA. - 13:(1996), pp. 1483-1488.

BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.

CONTE, Pierfranco;
1996

Abstract

BRCA1 germline mutations confer susceptibility to familial breast and ovarian cancer. Mutational hot spots have never been detected in BRCA1 cDNA. Some mutations have been reported several times whereas some others appear to be population-related. In this study a group of 36 Italian families were analysed for BRCA1 germline mutations. All of them were screened by allele-specific oligonucleotide hybridization (ASO) for three recurrent mutations (185delAG, 5382insC, nt332-T>G). Twenty families, selected because of their high risk of carrying BRCA1 mutations, were subjected to analysis of the entire coding sequence of the gene. A total of eight mutations were found. ASO screening demonstrated only one known mutation in one patient, whereas cycle sequencing revealed five new mutations. Three of these new mutations were frameshifts: one occurred in exon 11 (1499insA), one in exon 16 (4873delCA) and one in the splice site of exon 3 (252delAAgt). Two were missense mutations (Cys64Arg; Asn158Tyr). The same frameshift mutation, 1499insA, was detected in three unrelated families. Haplotype analysis supported the hypothesis that two of these families may have had common ancestors, whereas in the third family the analysis was uninformative. BRCA1 germline mutations were found in one out of two families with ovarian cancer, in five out of eight families with breast-ovarian cancer, and in two out of 11 families with breast cancer. All three families with 1499insA mutations included at least one case of ovarian cancer. The majority of the ovarian cancers (4/5) associated with detectable BRCA1 germline mutations were of serous histotype.
1996
13
1483
1488
BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations / M. A., Caligo; C., Ghimenti; G., Cipollini; S., Ricci; I., Brunetti; V., Marchetti; R., Olsen; S., Neuhausen; D., Shattuck Eidens; Conte, Pierfranco; M. H., Skolnick; G., Bevilacqua. - In: ONCOGENE. - ISSN 0950-9232. - STAMPA. - 13:(1996), pp. 1483-1488.
M. A., Caligo; C., Ghimenti; G., Cipollini; S., Ricci; I., Brunetti; V., Marchetti; R., Olsen; S., Neuhausen; D., Shattuck Eidens; Conte, Pierfranco; M. H., Skolnick; G., Bevilacqua
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/739332
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 45
social impact